Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: hydroxychloroquine|DRUG: ixabepilone
Sponsor: University of Medicine and Dentistry of New Jersey
Collaborators: National Cancer Institute (NCI)